Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: a systematic review
AH Simoni, J Frydenlund, KH Kragholm… - International journal of …, 2022 - Elsevier
Background Socioeconomic inequities in acute coronary syndrome (ACS) epidemiology and
care have been reported for at least 30–40 years. However, an up-to-date overview of …
care have been reported for at least 30–40 years. However, an up-to-date overview of …
The influence of patient expectations on adherence to treatment regimen after myocardial infarction
Ł Pietrzykowski, M Kasprzak, P Michalski… - Patient education and …, 2022 - Elsevier
Objective In-hospital patient education is one of the elements affecting patient adherence to
treatment regimen after myocardial infarction (MI). Its effectiveness is determined by …
treatment regimen after myocardial infarction (MI). Its effectiveness is determined by …
Functioning of patients with post-COVID syndrome—preliminary data
A Kubica, P Michalski, M Kasprzak… - Medical Research …, 2021 - journals.viamedica.pl
Introduction: Post-COVID syndrome is a common finding during the first year after SARS-
CoV-2 infection affecting the daily living of many patients. The aim of this study was to …
CoV-2 infection affecting the daily living of many patients. The aim of this study was to …
Functioning in chronic disease—a key factor determining adherence to heart failure treatment
Patients with heart failure require long-term medical treatment [1, 2]. Non-adherence to
medication is the main factor limiting treatment efficacy due to increased morbidity and …
medication is the main factor limiting treatment efficacy due to increased morbidity and …
[PDF][PDF] The therapeutic plan implementation in patients discharged from the hospital after myocardial infarction
A Kubica, Ł Pietrzykowski - Medical Research Journal, 2021 - journals.viamedica.pl
According to the European Society of Cardiology guidelines dual antiplatelet therapy
(DAPT) for 12 months, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin …
(DAPT) for 12 months, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin …
Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients
Several mechanisms have been suggested to explain positive cardiovascular effects
observed in studies with sodium-glucose co-transporter 2 (SGLT2) inhibitors. The reduction …
observed in studies with sodium-glucose co-transporter 2 (SGLT2) inhibitors. The reduction …
[HTML][HTML] A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo …
The risk of ischemic events gradually decreases after acute coronary syndrome (ACS),
reaching a stable level after 1 month, while the risk of bleeding remains steady during the …
reaching a stable level after 1 month, while the risk of bleeding remains steady during the …
Implementation of therapeutic recommendations in high cardiovascular-risk patients. The Polish population of EUROASPIRE V survey
E Laskowska, P Michalski… - Medical Research …, 2021 - journals.viamedica.pl
Introduction: Poor medication adherence is associated with unsatisfactory health outcomes,
elevated mortality, and high costs of medical care. This study aimed to assess the …
elevated mortality, and high costs of medical care. This study aimed to assess the …
Efficacy of double vs. standard empagliflozin dose for METabolic syndromE tReatment (DEMETER—SIRIO 11) study. Rationale and protocol of the study
Complex metabolic disorders associated with obesity and diabetes pose a serious
therapeutic challenge. The DEMETER-SIRIO 11 study is a phase III, multicenter …
therapeutic challenge. The DEMETER-SIRIO 11 study is a phase III, multicenter …
[HTML][HTML] Приверженность терапии после перенесенного инфаркта миокарда и методы ее улучшения
АМ Щинова, АВ Потехина, ЮА Долгушева… - Атеросклероз и …, 2022 - cyberleninka.ru
На настоящий момент приверженность медикаментозной терапии у лиц с сердечно-
сосудистыми заболеваниями, в частности после перенесенного инфаркта миокарда …
сосудистыми заболеваниями, в частности после перенесенного инфаркта миокарда …